Here, we report the creation of a unique formulation for our first-in- class FSH-blocking humanized antibody, MS-Hu6, which we propose to move to the clinic for osteoporosis, obesity, and Alzheimer's disease. The gene discussed is BRD2; the disease is obesity due to melanocortin 4 receptor deficiency.